Alveron Pharma is developing a unique coagulation
platform technology with the world's first
cyclodextrin-based anticoagulant reversal drug
Alveron Pharma is developing a unique coagulation
platform technology with the world's first
cyclodextrin-based anticoagulant reversal drug